|
|
41
|
|
|
A5015
|
|
|
DIOVAN 160MG TAB (NVS) VALSARTAN
|
|
|
VALSARTAN
|
|
|
DIOVAN
|
|
|
14'S
|
|
|
A
|
|
|
9.08
|
|
|
0.6486
|
|
|
160MG
|
|
|
TAB
|
|
|
30
|
|
|
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Hypertensive
|
|
|
2024-09-06
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
1 OD
|
|
|
1
|
|
|
N
|
|
|
243208
|
|
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
2024-09-06
|